Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide does not cause gastroenteritis in the clinical sense — it cannot give you a viral or bacterial gut infection. What it does do is slow digestion and affect the gut lining in ways that produce symptoms people often mistake for a stomach bug: nausea, loose stools, vomiting, and cramping. That confusion is understandable, and worth unpicking carefully. Semaglutide (the active ingredient in Wegovy) is a prescription-only medicine, and any significant or persistent gut symptoms should be discussed with your prescriber rather than managed alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
One of the most common things people say when they start semaglutide is that they felt as if they'd caught a gastroenteritis bug in the first couple of weeks. The nausea, the unsettled bowels, the occasional vomiting, it maps onto a stomach bug closely enough that some people search for confirmation that their medicine has infected them somehow. It hasn't. That is worth saying plainly: semaglutide is not infectious, it does not harbour pathogens, and it cannot transmit or trigger viral or bacterial gastroenteritis.
What it does do is alter gut motility in a fairly dramatic way, at least initially. Semaglutide activates GLP-1 receptors throughout the digestive tract, slowing the rate at which the stomach empties into the small intestine. Food sits longer, gut pressure changes, and signals between the gut and brain shift significantly. The result is a cluster of gastrointestinal effects that feel unpleasant in ways that have nothing to do with infection and everything to do with your body adapting to a new hormonal signal. The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, stomach pain and indigestion as commonly reported effects, all of which overlap with what people call a stomach bug.
The distinction matters because the management differs. A stomach bug is treated with rest, fluids and time. GI effects from semaglutide are managed by eating smaller meals, staying well hydrated, and sometimes by adjusting the pace of dose escalation with your prescriber. Treating one as the other delays getting the right support.
Slowed gastric emptying is a feature of semaglutide's mechanism, not a side effect in the sense of something unexpected. By keeping food in the stomach longer, the medicine amplifies satiety signals and reduces appetite, which is part of how it supports weight loss. But that same mechanism also means the stomach is doing more work for longer, and for many people that translates to nausea, particularly in the hours after eating.
Loose stools or diarrhoea typically arise from changes in gut transit time and alterations to gut hormone signalling further down the digestive tract. Constipation can occur instead, particularly as treatment continues and the body adapts. Both patterns are reported, and they can alternate. Some people also ask whether the medicine can irritate the stomach lining itself, and our page on whether Wegovy can cause gastritis looks at that question in detail. The symptoms are generally most pronounced in the first two to four weeks of treatment and after each dose step upward, then settle as the body adjusts. Not everyone experiences them, some people report barely any GI disruption at all.
If you are wondering how gut effects compare across different semaglutide doses, or whether the tablet formulation affects the pattern, our page on how semaglutide works covers the mechanism in more detail. Eating smaller portions, avoiding high-fat meals and taking time over food are practical adjustments that most prescribers recommend from the outset.
The danger zone (and it is real) is when gastrointestinal symptoms become severe or prolonged. Persistent vomiting and diarrhoea, whatever their cause, carry a risk of dehydration. On semaglutide, dehydration is a particular concern because it can affect kidney function if it goes unchecked. Our page on dehydration and Wegovy explores this in more detail, but the short version is: if you cannot keep fluids down, that is a signal to contact your prescriber or seek medical attention, not to wait it out.
There is also a separate, rarer risk that is worth knowing about. In January 2026, the MHRA issued a Drug Safety Update drawing attention to acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines. Pancreatitis can present as severe stomach pain radiating to the back, sometimes with vomiting, and should not be confused with ordinary GI side effects or dismissed as a stomach bug. If you develop severe, persistent abdominal pain of that character, seek urgent medical attention and do not wait for a routine call-back. You can report any suspected side effects (including unexpected gut symptoms) through the MHRA Yellow Card scheme.
If, beyond the gut, you are curious about other questions people ask about semaglutide's side-effect profile, our page covering semaglutide and other reported effects addresses some of the less-discussed queries.
Because semaglutide is a prescription-only medicine, the management of its side effects is not something to navigate alone. The titration schedule exists precisely to reduce the GI burden: starting at a low dose and increasing gradually gives your gut time to adapt, and a prescriber can slow that pace if your symptoms are making treatment difficult to tolerate. Stopping and restarting without guidance, or skipping doses to avoid nausea, can make the adjustment period longer and harder.
It is also worth understanding the cost picture if you are weighing up private treatment. Our Wegovy cost guide explains what private prescriptions typically include and why transparent pricing matters for a medicine with ongoing clinical oversight built in.
If gastric-type symptoms are getting in the way of your treatment, or if you are not yet on semaglutide and want to understand whether it is suitable for you, a prescriber is the right person to consult. At nume, a GPhC-registered Independent Prescriber reads every consultation personally, on the day it arrives. Check your eligibility and start your free consultation to speak with our clinical team about your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.